Third, immunologically, metformin exerts antitumor activities by increasing CD8+ T cells [49, 50], inhibiting apoptosis of CD8+ tumor-infiltrating lymphocytes [49, 51], and neutralizing immune-inhibitory cell populations in the tumor microenvironment [52] to realize effective cancer immunotherapy. The gene discussed is CD8A; the disease is cancer.